The build vs
NF-B Pathway Inhibition (Primary Mechanism) KPVs most well-characterized mechanism is inhibition of NF-B (nuclear factor kappa-light-chain-enhancer of activated B cells), the master regulator of inflammation: Cellular Entry via PepT1: KPV enters inflamed cells through PepT1 transporter (oligopeptide transporter 1) Nuclear Translocation Block: Prevents NF-B translocation from cytoplasm to nucleus Transcription Inhibition: Blocks NF-B-mediated transcription of pro-inflammatory genes Cytokine Reduction: Decreases IL-1, IL-6, TNF-, IL-8 production 2
Gastrointestinal discomfort and nausea are the most common side effects, but those related to patients' physical appearance often receive the most attention
For the OGD phase, cells were washed twice with PBS and then incubated in glucose-free DMEM (Gibco, Thermo Fisher Scientific, Waltham, MA, United States) under hypoxic conditions (1% O 2 , 94% N 2 , 5% CO 2 ) in a hypoxia chamber (BioSpherix, Parish, NY, United States) for 8 h